Acute Lymphoblastic Leukemia — Trials

Acute Lymphoblastic Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

2,037 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 546
Recruiting: 330
Ph III recruiting: 26
Growth YoY: −10%
Industry share: 13%
Top sponsor: City of Hope Medical Center
Termination share: 33.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (268)

clinicaltrialsPublishedShowing 51–100 of 248 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07192237	Phase 2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Patients With Measurable Residual Disease Positive B-cell Acute Lymphoblastic Leukemia	not yet recruiting	Phase 2	40	M.D. Anderson Cancer CenterOTHER	1	Aug 12, 2026	clinicaltrials
NCT03573700	Evaluation of CD19-Specific CAR Engineered Autologous T-Cells for Treatment of Relapsed/Refractory CD19+ Acute Lymphoblastic Leukemia	active not recruiting	Phase 1 / Phase 2	24	St. Jude Children's Research HospitalOTHER	1